These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 19190559
1. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study. Parisi R, Visonà A, Camporese G, Verlato F, Lessiani G, Antignani PL, Palareti G. Int Angiol; 2009 Feb; 28(1):68-72. PubMed ID: 19190559 [Abstract] [Full Text] [Related]
2. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P, Behounek J, Skoták M, Nevsímal L. Acta Chir Orthop Traumatol Cech; 2004 Feb; 71(4):237-44. PubMed ID: 15456102 [Abstract] [Full Text] [Related]
3. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis. Singh K, Yakoub D, Giangola P, DeCicca M, Patel CA, Marzouk F, Giangola G. J Vasc Surg; 2012 Jan; 55(1):136-40. PubMed ID: 21982332 [Abstract] [Full Text] [Related]
4. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression. Labas P, Ohrádka B, Vladimír J, Cambal M. Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727 [Abstract] [Full Text] [Related]
5. Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis. Results from the OTIS-DVT Registry. Spirk D, Husmann M, Willenberg T, Banyai M, Frank U, Baldi T, Amann-Vesti B, Baumgartner I, Kucher N. Thromb Haemost; 2011 Feb; 105(2):239-44. PubMed ID: 20886197 [Abstract] [Full Text] [Related]
6. Low molecular weight heparin for deep vein thrombosis in glioma patients. Schmidt F, Faul C, Dichgans J, Weller M. J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158 [Abstract] [Full Text] [Related]
14. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis. Lopaciuk S, Bielska-Falda H, Noszczyk W, Bielawiec M, Witkiewicz W, Filipecki S, Michalak J, Ciesielski L, Mackiewicz Z, Czestochowska E, Zawilska K, Cencora A. Thromb Haemost; 1999 Jan 30; 81(1):26-31. PubMed ID: 9974369 [Abstract] [Full Text] [Related]
15. Deep venous thrombosis in children and adolescents. Levy ML, Granville RC, Hart D, Meltzer H. J Neurosurg; 2004 Aug 30; 101(1 Suppl):32-7. PubMed ID: 16206969 [Abstract] [Full Text] [Related]
17. [Protocol for ambulant treatment of deep venous thrombosis in a leg: efficacious and safe in general practice]. van Hulsteijn LH, Brenninkmeijer BJ, Trügg RA, Litjens-van de Ven AJ, Huisman MV. Ned Tijdschr Geneeskd; 2000 Mar 18; 144(12):557-60. PubMed ID: 10746047 [Abstract] [Full Text] [Related]
20. Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. Siragusa S, Anastasio R, Porta C, Falaschi F, Pirrelli S, Palmieri P, Gamba G, Granzow K, Malato A, Minardi V, Tatoni P, Bressan MA, Mariani G. Arch Intern Med; 2000 Mar 18; 164(22):2477-82. PubMed ID: 15596639 [Abstract] [Full Text] [Related] Page: [Next] [New Search]